MitraClip® After Surgical Mitral Valve Repair (MVRepair)

LMU Klinikum

Status: Unknown

Conditions: Mitral Regurgitation

Treatments: Device: Percutaneous edge-to-edge repair of the mitral valve

Study type: Observational

Funder types: Other

Identifiers

NCT02853955

GE IDE MucS001-16

Details and patient eligibility

About

Percutaneous edge-to-edge repair of the mitral valve has been shown to be a safe and effective alternative treatment option for selected patients at high risk for cardiac surgery. Patients with recurrent mitral regurgitation after surgical mitral valve repair (sMVR) are per se at increased risk for another cardiac surgery. The purpose of this multicenter retrospective analysis of patients treated with a MitraClip® after sMVR, is to evaluate the effectiveness and durability of this minimally invasive treatment option in this subset of patients.

Full description

In this multicenter retrospective analysis of MitraClip® cases after MVR the effectiveness and durability of this minimally invasive treatment option in this subset of patients will be evaluated.

Enrollment: 30 estimated patients

Sex: All

Ages: 18 to 95 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients with recurrent mitral regurgitation treated with a MitraClip®.

Exclusion criteria

• Patient with endocarditis,
• Patients with torn mitral valve ring.